在HER2阳性乳腺癌中对Trastuzumab deruxtecan的异常反应:两个说明性的病例报告
Zelmira Ballatore1, Helene Vanacker2, Rita Chiari1
1UOC Oncologia, Azienda Sanitaria Territoriale Pesaro Urbino, Urbino, Italy.
Frontiers in oncology
|November 7, 2025
概括
特拉斯图祖马布德鲁克斯泰干 (T-DXd) 在转移性HER2阳性乳腺癌中显示长期缓解. 这些病例表明,即使在停止T-DXd治疗后,持续的益处仍然存在.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 特拉斯图祖马布德鲁克斯泰坎 (T-DXd) 是一种针对HER2的抗体药物联合体.
- 在转移性HER2阳性乳腺癌中,T-DXd显示出显著的临床活性.
研究的目的:
- 报告T-DXd在转移性HER2阳性乳腺癌中持续临床益处的病例.
- 调查T-DXd治疗中止后长期缓解的可能性.
主要方法:
- 两名患有转移性HER2阳性乳腺癌的患者的病例报告,接受T-DXd治疗.
- 详细观察治疗反应,持续时间和治疗暂停后的结果.
主要成果:
- 患者1在50个月内实现了反应,包括36个月的完全缓解治疗后停药.
- 患者2保持了超过39个月的疾病控制,并进行了长时间的治疗暂停.
- 两位患者都表现出超出预期的显著疾病稳定性.
结论:
- T-DXd可以诱导深度和持久的反应,可能在药物暴露之后维持缓解.
- 这些发现挑战了转移性HER2阳性乳腺癌的不可治愈性范式.
- 需要进一步的研究,以了解对T-DXd的长期反应的机制和预测因素.
更多相关视频
13:59High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
Published on: August 18, 2023
2.7K
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
3.7K
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
